NCT03253354 is a NA clinical trial of repetitive magnetic stimulation in Dysphagia, sponsored by University of Manchester.

Who is sponsoring NCT03253354?

NCT03253354 is sponsored by University of Manchester.

What drugs are being tested in NCT03253354?

Interventions in NCT03253354: repetitive magnetic stimulation.

What condition does NCT03253354 study?

NCT03253354 studies Dysphagia, Parkinson Disease, Swallowing Disorder.Other Specified, Brain Diseases.

Is NCT03253354 still recruiting?

NCT03253354 is currently completed. Last updated 9 June 2022.

Last reviewed 2022-06-09 · How we verify

NCT03253354

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neurostimulation for Dysphagia in Parkinson's Disease

Completed NA Last updated 9 June 2022

What this trial tests

NA trial testing repetitive magnetic stimulation in Dysphagia in 12 participants. Completed in 30 August 2021.

Timeline

1 August 2017

Primary endpoint
30 April 2021

30 August 2021

Quick facts

Lead sponsor	University of Manchester
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	12
Start date	1 August 2017
Primary completion	30 April 2021
Estimated completion	30 August 2021
Sites	1 location across United Kingdom

Drugs / interventions tested

repetitive magnetic stimulation

Conditions studied

Dysphagia — all drugs for Dysphagia →
Parkinson Disease — all drugs for Parkinson Disease →
Swallowing Disorder.Other Specified — all drugs for Swallowing Disorder.Other Specified →
Brain Diseases — all drugs for Brain Diseases →

Sponsor

University of Manchester

Who can join

18 and older, any sex, with Dysphagia or Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will explore the effects of 3 different neurostimulation methods on swallowing function in patients with dysphagia secondary to Parkinson's Disease

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A feasibility pilot study of the effects of neurostimulation on swallowing function in Parkinson's Disease [version 2; peer review: 1 approved, 3 approved with reservations, 1 not approved].
Sasegbon A, Hammerbeck U, Michou E, Cheng I, et al · · 2022 · cited 6× · PMID 35726231 · DOI 10.12688/amrcopenres.13007.2
A Meta-Analysis and Systematic Review of the Effects of Sensory Modulation Treatments for Neurogenic Oropharyngeal Dysphagia.
Dai M, Cheng I, Sasegbon A, Li W, et al · · 2025 · cited 1× · PMID 40625241 · DOI 10.1111/cns.70452

Verify or expand the search:

Other recruiting trials for Dysphagia

Currently open trials in the same condition.

NCT07027826 — The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in · NA · recruiting
NCT07264036 — Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study · NA · recruiting
NCT07517926 — Chewing Gum and Cold Gargle on Post-Bronchoscopy Symptoms · NA · recruiting
NCT07251140 — Dysphagia Study Using Novel Microphone Device · NA · recruiting
NCT07076524 — MuScle WastIng and DysphaGia iN CriticAlly IlL Patients (SIGNAL) · recruiting

Other University of Manchester trials

Trials by the same sponsor.

NCT07506096 — Using IF-THEN Plans to Support Healthcare Professionals in Raising Patient Safety Concerns · NA · not yet recruiting
NCT07084090 — Using IF-THEN Plans to Support Patients in Raising Safety Concerns About Their Care · NA · not yet recruiting
NCT07494760 — A Feasibility Randomised Control Trial to Evaluate Early Perinatal Bereavement Counselling for Parents Who Have Experien · NA · not yet recruiting
NCT07372885 — GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia · Phase 1, PHASE2 · not yet recruiting
NCT07381894 — Multicentre Hypertrophic Cardiomyopathy Registry · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03253354 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Manchester
Last refreshed: 9 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03253354.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing